Jing Xi

492 total citations
12 papers, 275 citations indexed

About

Jing Xi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Jing Xi has authored 12 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Jing Xi's work include Advanced Breast Cancer Therapies (5 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Genomics and Diagnostics (2 papers). Jing Xi is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Genomics and Diagnostics (2 papers). Jing Xi collaborates with scholars based in United States, China and Germany. Jing Xi's co-authors include X. Cynthia, Jeffrey L. Ebersole, Mohanad Al‐Sabbagh, Craig S. Miller, Jingqin Luo, Richard J. Kryscio, Xiuhua Ding, Shana Thomas, Jian Campian and Bilal Hassan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Sensors.

In The Last Decade

Jing Xi

11 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Xi United States 6 154 126 75 52 50 12 275
Elizabete Bagordakis Pinto Brazil 9 70 0.5× 29 0.2× 52 0.7× 41 0.8× 37 0.7× 10 335
Hongzhi Quan China 10 72 0.5× 35 0.3× 47 0.6× 56 1.1× 12 0.2× 24 262
LP Kowalski Brazil 10 100 0.6× 48 0.4× 35 0.5× 63 1.2× 2 0.0× 15 305
Andrea Gabusi Italy 11 57 0.4× 21 0.2× 94 1.3× 101 1.9× 6 0.1× 31 311
Anna Sophie Hoffmann Germany 8 111 0.7× 24 0.2× 37 0.5× 43 0.8× 3 0.1× 18 300
Shengjin Dou China 10 208 1.4× 83 0.7× 13 0.2× 29 0.6× 3 0.1× 36 347
Luca Sala Italy 8 92 0.6× 58 0.5× 47 0.6× 10 0.2× 21 0.4× 24 191
Christoph Baran Germany 10 110 0.7× 29 0.2× 58 0.8× 148 2.8× 3 0.1× 14 334
Masahiro Wato Japan 12 93 0.6× 19 0.2× 22 0.3× 33 0.6× 6 0.1× 62 318
Valeria Navach Italy 8 97 0.6× 68 0.5× 14 0.2× 26 0.5× 6 0.1× 11 292

Countries citing papers authored by Jing Xi

Since Specialization
Citations

This map shows the geographic impact of Jing Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Xi more than expected).

Fields of papers citing papers by Jing Xi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Xi. The network helps show where Jing Xi may publish in the future.

Co-authorship network of co-authors of Jing Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Xi. A scholar is included among the top collaborators of Jing Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Xi. Jing Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Xi, Jing, X. Cynthia, & Joyce O’Shaughnessy. (2024). Current Clinical Utility of Circulating Tumor DNA Testing in Breast Cancer: A Practical Approach. JCO Oncology Practice. 20(11). 1460–1470. 2 indexed citations
3.
Yan, Mingjuan, et al.. (2024). NF-κB/miR-455-5p/SOCS3 Axis Aggravates Sepsis-Induced Acute Kidney Injury through Promoting Renal Inflammation. ˜The œNephron journals/Nephron journals. 149(2). 1–12. 1 indexed citations
4.
Clifton, Katherine, X. Cynthia, Jingqin Luo, et al.. (2024). Abstract PO5-05-05: Clinical outcomes of CDK4/6 inhibitors in patients with bone only metastatic breast cancer. Cancer Research. 84(9_Supplement). PO5–5. 1 indexed citations
5.
Xi, Jing, Bilal Hassan, Karam Khaddour, et al.. (2021). The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma. BMC Cancer. 21(1). 285–285. 4 indexed citations
6.
7.
Xi, Jing & X. Cynthia. (2020). Sequencing Endocrine Therapy for Metastatic Breast Cancer: What Do We Do After Disease Progression on a CDK4/6 Inhibitor?. Current Oncology Reports. 22(6). 57–57. 29 indexed citations
8.
Xi, Jing, Hongying Jiang, Ning Zhang, et al.. (2019). Respiratory muscle endurance training with normocapnic hyperpnoea for patients with chronic spinal cord injury: A pilot short-term randomized controlled trial. Journal of Rehabilitation Medicine. 51(8). 0–0. 6 indexed citations
9.
Xi, Jing, Amit M. Oza, Shana Thomas, et al.. (2019). Retrospective Analysis of Treatment Patterns and Effectiveness of Palbociclib and Subsequent Regimens in Metastatic Breast Cancer. Journal of the National Comprehensive Cancer Network. 17(2). 141–147. 61 indexed citations
10.
Xi, Jing, Jingqin Luo, Bilal Hassan, et al.. (2019). Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer. Breast Cancer Research and Treatment. 174(2). 443–452. 54 indexed citations
11.
Wander, Seth A., Mark L. Zangardi, Andrzej Niemierko, et al.. (2019). A multicenter analysis of abemaciclib after progression on palbociclib in patients (pts) with hormone receptor-positive (HR+)/HER2- metastatic breast cancer (MBC).. Journal of Clinical Oncology. 37(15_suppl). 1057–1057. 26 indexed citations
12.
Al‐Sabbagh, Mohanad, Richard J. Kryscio, Jing Xi, et al.. (2014). Salivary Biomarkers Associated With Gingivitis and Response to Therapy. Journal of Periodontology. 85(8). e295–303. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabete Bagordakis Pinto Breakdown of academic impact, for papers by Hongzhi Quan Breakdown of academic impact, for papers by LP Kowalski Breakdown of academic impact, for papers by Andrea Gabusi Breakdown of academic impact, for papers by Anna Sophie Hoffmann Breakdown of academic impact, for papers by Shengjin Dou Breakdown of academic impact, for papers by Luca Sala Breakdown of academic impact, for papers by Christoph Baran Breakdown of academic impact, for papers by Masahiro Wato Breakdown of academic impact, for papers by Valeria Navach
Rankless by CCL
2026